| Product Code: ETC7354808 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Oncology NGS Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Oncology NGS Market - Industry Life Cycle |
3.4 Greece Oncology NGS Market - Porter's Five Forces |
3.5 Greece Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Greece Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Greece Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Greece Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Greece Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Greece Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Greece |
4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology diagnostics |
4.2.3 Government initiatives and funding to support cancer research and treatment in Greece |
4.3 Market Restraints |
4.3.1 High costs associated with NGS technology and tests |
4.3.2 Lack of skilled professionals in the field of oncology genetics in Greece |
4.3.3 Regulatory challenges and complexity in implementing NGS technology in oncology practices |
5 Greece Oncology NGS Market Trends |
6 Greece Oncology NGS Market, By Types |
6.1 Greece Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Greece Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Greece Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Greece Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Greece Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Greece Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Greece Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Greece Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Greece Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Greece Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Greece Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Greece Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Greece Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Greece Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Greece Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Greece Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Greece Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Greece Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Greece Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Greece Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Greece Oncology NGS Market Import-Export Trade Statistics |
7.1 Greece Oncology NGS Market Export to Major Countries |
7.2 Greece Oncology NGS Market Imports from Major Countries |
8 Greece Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for oncology NGS tests |
8.2 Number of oncology clinics/hospitals adopting NGS technology |
8.3 Rate of accuracy and reliability of NGS tests in oncology diagnostics |
9 Greece Oncology NGS Market - Opportunity Assessment |
9.1 Greece Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Greece Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Greece Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Greece Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Greece Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Greece Oncology NGS Market - Competitive Landscape |
10.1 Greece Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Greece Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here